214 related articles for article (PubMed ID: 19929202)
1. Design of a 24-hour controlled porosity osmotic pump system containing PVP: formulation variables.
Yakubu R; Peh KK; Tan YT
Drug Dev Ind Pharm; 2009 Dec; 35(12):1430-8. PubMed ID: 19929202
[TBL] [Abstract][Full Text] [Related]
2. Applicability of (SBE)7m-beta-CD in controlled-porosity osmotic pump tablets (OPTs).
Okimoto K; Tokunaga Y; Ibuki R; Irie T; Uekama K; Rajewski RA; Stella VJ
Int J Pharm; 2004 Nov; 286(1-2):81-8. PubMed ID: 15501004
[TBL] [Abstract][Full Text] [Related]
3. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo evaluation of novel osmotic pump tablets of isosorbide-5-mononitrate containing polyvinyl pyrrolidone (PVP) for controlled release.
Li X; Jiang Q; Du L; Wang C; Chi Q
Pharmazie; 2012 Aug; 67(8):695-700. PubMed ID: 22957434
[TBL] [Abstract][Full Text] [Related]
5. Effects of formulation and process variables on the release of a weakly basic drug from single unit extended release formulations.
Kranz H; Wagner T
Eur J Pharm Biopharm; 2006 Jan; 62(1):70-6. PubMed ID: 16154330
[TBL] [Abstract][Full Text] [Related]
6. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.
Liu H; Yang XG; Nie SF; Wei LL; Zhou LL; Liu H; Tang R; Pan WS
Int J Pharm; 2007 Mar; 332(1-2):115-24. PubMed ID: 17052871
[TBL] [Abstract][Full Text] [Related]
7. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
Emara LH; Taha NF; Badr RM; Mursi NM
Drug Discov Ther; 2012 Oct; 6(5):269-77. PubMed ID: 23229148
[TBL] [Abstract][Full Text] [Related]
8. A novel solubility-modulated granules through porosity osmotic pump for controlled carvedilol delivery.
Song QL; Li P; Li YM
Pharm Dev Technol; 2012; 17(6):666-76. PubMed ID: 21486184
[TBL] [Abstract][Full Text] [Related]
9. Sandwiched osmotic tablet core for nifedipine controlled delivery.
Liu L; Khang G; Rhee JM; Lee HB
Biomed Mater Eng; 1999; 9(5-6):297-310. PubMed ID: 10822485
[TBL] [Abstract][Full Text] [Related]
10. Dissolution rate and stability study of flavanone aglycones, naringenin and hesperetin, by drug delivery systems based on polyvinylpyrrolidone (PVP) nanodispersions.
Kanaze FI; Kokkalou E; Niopas I; Barmpalexis P; Georgarakis E; Bikiaris D
Drug Dev Ind Pharm; 2010 Mar; 36(3):292-301. PubMed ID: 19663560
[TBL] [Abstract][Full Text] [Related]
11. Studies on controlled release effervescent osmotic pump tablets from Traditional Chinese Medicine Compound Recipe.
Li XD; Pan WS; Nie SF; Wu LJ
J Control Release; 2004 May; 96(3):359-67. PubMed ID: 15120893
[TBL] [Abstract][Full Text] [Related]
12. Asymmetric membrane capsules for delivery of poorly water-soluble drugs by osmotic effects.
Wang CY; Ho HO; Lin LH; Lin YK; Sheu MT
Int J Pharm; 2005 Jun; 297(1-2):89-97. PubMed ID: 15885936
[TBL] [Abstract][Full Text] [Related]
13. Design and evaluation of osmotic pump-based controlled release system of Ambroxol Hydrochloride.
Cheng X; Sun M; Gao Y; Cao F; Zhai G
Pharm Dev Technol; 2011 Aug; 16(4):392-9. PubMed ID: 20429827
[TBL] [Abstract][Full Text] [Related]
14. Development of a single unit extended release formulation for ZK 811 752, a weakly basic drug.
Kranz H; Guthmann C; Wagner T; Lipp R; Reinhard J
Eur J Pharm Sci; 2005 Sep; 26(1):47-53. PubMed ID: 15953712
[TBL] [Abstract][Full Text] [Related]
15. [Design push-pull osmotic pump tablets of famotidine based on an expert system for the formulation design of osmotic pump of poor water-soluble drug].
Zhang ZH; Jin J; Zhang HW; Xin W; Jia GB; Wu WF; Pan WS
Yao Xue Xue Bao; 2011 Jan; 46(1):109-14. PubMed ID: 21465816
[TBL] [Abstract][Full Text] [Related]
16. Production and
Ma C; Huang Z; Zhu Y; Chen X; Singh V; Huang Y; Pan X; Wu C
Pharmazie; 2017 Sep; 72(9):511-517. PubMed ID: 29441977
[TBL] [Abstract][Full Text] [Related]
17. Design of an expert system for the development and formulation of push-pull osmotic pump tablets containing poorly water-soluble drugs.
Zhang ZH; Dong HY; Peng B; Liu HF; Li CL; Liang M; Pan WS
Int J Pharm; 2011 May; 410(1-2):41-7. PubMed ID: 21419199
[TBL] [Abstract][Full Text] [Related]
18. [Formulation optimization of controlled porosity osmotic-pump tablets of total paeony glycosides].
Zhang H; Wang WP
Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(19):2185-7. PubMed ID: 19166002
[TBL] [Abstract][Full Text] [Related]
19. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
Dhumal RS; Shimpi SL; Paradkar AR
Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
[TBL] [Abstract][Full Text] [Related]
20. Preparation of monolithic osmotic pump system by coating the indented core tablet.
Liu L; Che B
Eur J Pharm Biopharm; 2006 Oct; 64(2):180-4. PubMed ID: 16797951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
